| Document Date: 2003-06-23 14:03:00
Open Document File Size: 78,73 KBShare Result on Facebook
City Washington / D.C. / / Company Eli Lilly / Johnson & Johnson / Wall Street Journal / Amgen / All Fortune 500 Companies / Coca-Cola / Toyota / Pfizer Inc. / Merck / IMS Health / Schering-Plough / Pharmacia / Wyeth / Hefty Pharmaceutical Company Margins Dwarf Other Industries / All Fortune 500 Industries / Abbott Laboratories / Immunex / Bristol-Myers Squibb / / Continent America / / Country United States / / Currency cent / USD / / Event M&A / Earnings Announcement / / / IndustryTerm pharmaceutical information / clean and safe energy sources / pharmaceutical industry / large pharmaceutical / campaign finance reform / glaucoma treatment / chemical compounds / insurance plans / pharmaceutical / direct-to-consumer advertising / pharmaceuticals / advertising budgets / pharmaceutical giants / personal bank accounts / public relations / / MedicalCondition glaucoma / arthritis / company’s arthritis / acid-reflux disease / asthma / disease / slow flu / allergy / / MedicalTreatment estrogen replacement therapy / / Organization MIT / Harvard / Public Citizen’s Publication Office / Public Citizen Public Citizen / Congress / FDA / / Person Doug Long / Ben Peck / April Greener / Luke Warren / Ralph Nader / Paul Wilson / Frank Clemente / Neal Pattison / / / Position Watch Director / Research Consultant / Watch Research Director / Legislative Assistant / Representative / analyst / / Product Effexor / Zyrtec / Zoloft / Lipitor / Premarin / Protonix / Xalatan / Celebrex / Enbrel / Singulair / Claritin / / PublishedMedium the Fortune / Wall Street Journal / / URL www.citizen.org / /
SocialTag |
2002 Drug Industry Profits: Hefty Pharmaceutical Company Margins Dwarf Other Industries Congress Watch June 2003